Prevalence of fetal anomalies, stillbirth, neonatal morbidity, or mortality in pregnancies complicated by placenta accreta spectrum disorders.
PAS
fetal abnormalities
neonatal death
placenta
placenta previa
stillbirth
Journal
Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343
Informations de publication
Date de publication:
14 Jul 2024
14 Jul 2024
Historique:
revised:
03
06
2024
received:
26
01
2024
accepted:
04
06
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
aheadofprint
Résumé
Placenta accreta spectrum disorders (PAS) lead to major complications in pregnancy. While the maternal morbidity associated with PAS is well known, there is less information regarding neonatal morbidity in this setting. The aim of this study is to describe the neonatal outcomes (fetal malformations, neonatal morbidity, twin births, stillbirth, and neonatal death), using an international multicenter database of PAS cases. This was a prospective, multicenter cohort study based on prospectively collected cases, using the international multicenter database of the International Society for PAS, carried out between January 2020 and June 2022 by 23 centers with experience in PAS care. All PAS cases were included, regardless of whether singleton or multiple pregnancies and were managed in each center according to their own protocols. Data were collected via chart review. Local Ethical Committee approval and Data Use Agreements were obtained according to local policies. There were 315 pregnancies eligible for inclusion, with 12 twin pregnancies, comprising 329 fetuses/newborns; 2 cases were excluded due to inconsistency of data regarding fetal abnormalities. For the calculation of neonatal morbidity and mortality, all elective pregnancy terminations were excluded, hence 311 pregnancies with 323 newborns were analyzed. In our cohort, 3 neonates (0.93%) were stillborn; of the 320 newborns delivered, there were 10 cases (3.13%) of neonatal death. The prevalence of major congenital malformations was 4.64% (15/323 newborns), most commonly, cardiovascular, central nervous system, and gastrointestinal tract malformations. The overall prevalence of major neonatal morbidity in pregnancies complicated by PAS was 47/311 (15.1%). There were no stillbirths, neonatal deaths, or fetal malformations in reported twin gestations. Although some outcomes may be too rare to detect within our cohort and data should be interpreted with caution, our observational data supports reassuring neonatal outcomes for women with PAS.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Petra Pateisky
(P)
Egle Savukyne
(E)
Frederic Chantraine
(F)
Pavel Calda
(P)
Gita Strindfors
(G)
Monica Maria Siaulys
(MM)
Petra Hanulikova
(P)
Ozhan M Turan
(OM)
Andrew Rubenstein
(A)
Albaro Jose Nieto-Calvache
(AJ)
Hooman Soleymani Majd
(HS)
Johannes J Duvekot
(JJ)
Anja Bluth
(A)
Ammar Al Naimi
(A)
Informations de copyright
© 2024 The Author(s). Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Références
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence‐based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75‐87.
Jauniaux E, Ayres‐de‐Campos D, Langhoff‐Roos J, Fox KA, Collins S, Diagnosis FPA. Management expert consensus P. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146:20‐24.
Hecht JL, Baergen R, Ernst LM, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod Pathol. 2020;33:2382‐2396.
Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:84‐91.
Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;219:B2‐B16.
Collins SL, Alemdar B, van Beekhuizen HJ, et al. Evidence‐based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220:511‐526.
Hobson SR, Kingdom JC, Murji A, et al. No. 383‐screening, diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can. 2019;41:1035‐1049.
Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta Praevia and placenta Accreta: Diagnosis and management: green‐top guideline No. 27a. BJOG. 2019;126:e1‐e48.
Morlando M, Schwickert A, Stefanovic V, et al. Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: a multinational database study. Acta Obstet Gynecol Scand. 2021;100(Suppl 1):41‐49.
Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004‐2006. Birth Defects Res A Clin Mol Teratol. 2010;88:1008‐1016.
American College of Obstetricians and Gynecologists; Society for Maternal‐Fetal Medicine in collaboration with, Metz TD, Berry RS, Fretts RC, Reddy UM, Turrentine MA. Obstetric care consensus #10: Management of Stillbirth: (replaces practice bulletin number 102, march 2009). Am J Obstet Gynecol. 2020;222:B2‐B20.
World Health Organization. Neonatal and perinatal mortality: country rage. 2006.
Management of Stillbirth: Obstetric care consensus No, 10. Obstet Gynecol. 2020;135:e110‐e132.
Hug L, You D, Blencowe H, et al. Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment. Lancet. 2021;398:772‐785.
Nieto AJ, Echavarria MP, Carvajal JA, et al. Placenta accreta: importance of a multidisciplinary approach in the Colombian hospital setting. J Matern Fetal Neonatal Med. 2020;33:1321‐1329.
Flores‐Mendoza H, Chandran AR, Hernandez‐Nieto C, et al. Outcomes in emergency versus electively scheduled cases of placenta accreta spectrum disorder managed by cesarean‐hysterectomy within a multidisciplinary care team. Int J Gynaecol Obstet. 2022;159:404‐411.
Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(218):e1‐e9.
Vinograd A, Wainstock T, Mazor M, et al. Placenta accreta is an independent risk factor for late pre‐term birth and perinatal mortality. J Matern Fetal Neonatal Med. 2015;28:1381‐1387.
Baldwin HJ, Patterson JA, Nippita TA, et al. Maternal and neonatal outcomes following abnormally invasive placenta: a population‐based record linkage study. Acta Obstet Gynecol Scand. 2017;96:1373‐1381.
Schneiderman M, Balayla J. A comparative study of neonatal outcomes in placenta previa versus cesarean for other indication at term. J Matern Fetal Neonatal Med. 2013;26:1121‐1127.
https://eu‐rd‐platform.jrc.ec.europa.eu/eurocat/eurocat‐data/prevalence_en
Kancherla V, Raisanen S, Gissler M, Kramer MR, Heinonen S. Placenta previa and risk of major congenital malformations among singleton births in Finland. Birth Defects Res A Clin Mol Teratol. 2015;103:527‐535.
Zhao H, Wong RJ, Stevenson DK. The impact of hypoxia in early pregnancy on placental cells. Int J Mol Sci. 2021;22:9675.
Llurba Olive E, Xiao E, Natale DR, Fisher SA. Oxygen and lack of oxygen in fetal and placental development, feto‐placental coupling, and congenital heart defects. Birth Defects Res. 2018;110:1517‐1530.
Moeini R, Dalili H, Kavyani Z, et al. Maternal and neonatal outcomes of abnormal placentation: a case‐control study. J Matern Fetal Neonatal Med. 2021;34:3097‐3103.
Zhong W, Zhu F, Li S, et al. Maternal and neonatal outcomes after planned or emergency delivery for placenta Accreta Spectrum: a systematic review and meta‐analysis. Front Med (Lausanne). 2021;8:731412.
Damhuis SE, Ganzevoort W, Gordijn SJ. Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology. Obstet Gynecol Clin N Am. 2021;48:267‐279.
Multifetal gestations: twin, triplet, and higher‐order multifetal pregnancies: ACOG practice bulletin, number 231. Obstet Gynecol. 2021;137:e145‐e162.
Miller HE, Leonard SA, Fox KA, Carusi DA, Lyell DJ. Placenta Accreta Spectrum among women with twin gestations. Obstet Gynecol. 2021;137:132‐138.
DI Girolamo R, Buca D, Galliani C, et al. Systematic review and meta‐analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology. Minerva. Obstet Gynecol. 2023;75:55‐61.
Iakovidou MC, Kolibianakis E, Zepiridis L, Venetis C. The role of endometrial scratching prior to in vitro fertilization: an updated systematic review and meta‐analysis. Reprod Biol Endocrinol. 2023;21:89.
Shamshirsaz AA, Carusi D, Shainker SA, et al. Characteristics and outcomes of placenta accreta spectrum in twins versus singletons: a study from the pan American Society for Placenta Accreta Spectrum (PAS(2)). Am J Obstet Gynecol. 2020;222:624‐625.
Braun T, van Beekhuizen HJ, Morlando M, Morel O, Stefanovic V, International Society for Placenta Accreta Spectrum (IS‐PAS). Developing a database for multicenter evaluation of placenta accreta spectrum. Acta Obstet Gynecol Scand. 2021;100(Suppl 1):7‐11.